AMISULPRIDE vs AMIVANTAMAB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
AMISULPRIDE vs AMIVANTAMAB: Safety Overview
| Metric | AMISULPRIDE | AMIVANTAMAB |
|---|---|---|
| Total FAERS Reports | 3,152 | 748 |
| Deaths Reported | 324 | 116 |
| Death Rate | 10.3% | 15.5% |
| Hospitalizations | 1,537 | 445 |
| Average Patient Age | 42.7 yrs | 63.5 yrs |
| % Female Patients | 41.3% | 65.3% |
| FDA Approval Date | Feb 26, 2020 | N/A |
| Manufacturer | Acacia Pharma Ltd | Janssen Biotech, Inc. |
| Route | INTRAVENOUS | INTRAVENOUS |
| Marketing Status | Prescription | N/A |